Research

Nobel laureate Thomas Südhof, MD, discusses his synapse research at last week’s Discovery Lecture.
October 10, 2019

Nobel laureate Südhof reviews his landmark signaling research

The human brain consists of perhaps as many as 1,000 trillion synapses, which transmit signals from one nerve cell to another with amazing speed, precision and plasticity.

By Bill Snyder
October 8, 2019

New leadership appointments for Pathology, Microbiology and Immunology

By Bill Snyder
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

By Paul Govern
Adriana Hung, MD, MPH, talks with patient Sylvester Norman, who is participating in the VA Department’s Million Veteran Program.
September 25, 2019

Study shines light on architecture of kidney disease

A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.

By Bill Snyder
array of test tubes with pipette dropping fluid into one
September 20, 2019

Guengerich, Sanders-Bush named ASPET fellows

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
September 19, 2019

Gamazon receives NIH Genomic Innovator Award

VUMC’s Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.

By Leigh MacMillan
September 19, 2019

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
By Craig Boerner
September 19, 2019

Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.
By Bill Snyder
September 9, 2019

Year two for Master’s Program in Biomedical Sciences

Vanderbilt's Master’s Program in Biomedical Sciences prepares students for a broad array of health professional careers.
By Bill Snyder
September 5, 2019

Team explores epilepsy-related brain disturbances

A team led by a neurosurgeon-scientist and an engineering professor who specializes in techniques for analyzing functional neuroimaging data has received a $3 million grant to study disturbances in brain networks related to attention lapses and cognitive deficits in patients with temporal lobe epilepsy.
By Pam Coyle
September 5, 2019

Zebrafish aid effort to regenerate damaged retinas

According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans.
By Bill Snyder
September 4, 2019

Novel treatment for Prader-Willi syndrome being tested at VUMC

A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.
By Leigh MacMillan
September 4, 2019

Partnership to help bring Zika virus therapy to clinic

Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.
By Bill Snyder
1 … 44 45 46 47 48 … 56